213 related articles for article (PubMed ID: 20620237)
1. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody.
Wang CH; Chiou SH; Chou CP; Chen YC; Huang YJ; Peng CA
Nanomedicine; 2011 Feb; 7(1):69-79. PubMed ID: 20620237
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy.
Ji J; Judkowski VA; Liu G; Wang H; Bunying A; Li Z; Xu M; Bender J; Pinilla C; Yu JS
Stem Cells Transl Med; 2014 Mar; 3(3):356-64. PubMed ID: 24375541
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
[TBL] [Abstract][Full Text] [Related]
4. [The CD133 polyclonal antibody generation and cancer stem cells identification].
Tian JL; Cai PL; Xia XQ; Li FH; Wang DH; Chen MN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):422-6. PubMed ID: 21827013
[TBL] [Abstract][Full Text] [Related]
5. Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.
Zhu X; Bidlingmaier S; Hashizume R; James CD; Berger MS; Liu B
Mol Cancer Ther; 2010 Jul; 9(7):2131-41. PubMed ID: 20587664
[TBL] [Abstract][Full Text] [Related]
6. Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells.
Prasad S; Gaedicke S; Machein M; Mittler G; Braun F; Hettich M; Firat E; Klingner K; Schüler J; Wider D; Wäsch RM; Herold-Mende C; Elsässer-Beile U; Niedermann G
Cancer Res; 2015 Jun; 75(11):2166-76. PubMed ID: 25840983
[TBL] [Abstract][Full Text] [Related]
7. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.
Bayin NS; Modrek AS; Dietrich A; Lebowitz J; Abel T; Song HR; Schober M; Zagzag D; Buchholz CJ; Chao MV; Placantonakis DG
PLoS One; 2014; 9(12):e116114. PubMed ID: 25541984
[TBL] [Abstract][Full Text] [Related]
8. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
9. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
10. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
[TBL] [Abstract][Full Text] [Related]
11. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
Skubitz AP; Taras EP; Boylan KL; Waldron NN; Oh S; Panoskaltsis-Mortari A; Vallera DA
Gynecol Oncol; 2013 Sep; 130(3):579-87. PubMed ID: 23721800
[TBL] [Abstract][Full Text] [Related]
13. Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.
Emlet DR; Gupta P; Holgado-Madruga M; Del Vecchio CA; Mitra SS; Han SY; Li G; Jensen KC; Vogel H; Xu LW; Skirboll SS; Wong AJ
Cancer Res; 2014 Feb; 74(4):1238-49. PubMed ID: 24366881
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous phenotype of human glioblastoma: in vitro study.
Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
[TBL] [Abstract][Full Text] [Related]
15. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
16. Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties.
Bostad M; Berg K; Høgset A; Skarpen E; Stenmark H; Selbo PK
J Control Release; 2013 Jun; 168(3):317-26. PubMed ID: 23567040
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo.
Huang J; Li C; Wang Y; Lv H; Guo Y; Dai H; Wicha MS; Chang AE; Li Q
Clin Immunol; 2013 Oct; 149(1):156-68. PubMed ID: 23994769
[TBL] [Abstract][Full Text] [Related]
18. Basic studies on radioimmunotargeting of CD133-positive HCT116 cancer stem cells.
Jin ZH; Sogawa C; Furukawa T; Saito Y; Aung W; Fujibayashi Y; Saga T
Mol Imaging; 2012; 11(6):445-50. PubMed ID: 23084245
[TBL] [Abstract][Full Text] [Related]
19. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
Kim JS; Shin DH; Kim JS
J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
[TBL] [Abstract][Full Text] [Related]
20. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis.
Nowacki M; Wisniewski M; Werengowska-Ciecwierz K; Roszek K; Czarnecka J; Łakomska I; Kloskowski T; Tyloch D; Debski R; Pietkun K; Pokrywczynska M; Grzanka D; Czajkowski R; Drewa G; Jundziłł A; Agyin JK; Habib SL; Terzyk AP; Drewa T
Oncotarget; 2015 Sep; 6(26):22776-98. PubMed ID: 26254295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]